Effect of sustained release baclofen on alleviation of gastro-esophageal reflux disease symptoms
Completed
- Conditions
- Gastroesophageal reflux diseaseOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
- Registration Number
- ACTRN12613000910707
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
patients with diagnosis of Gastroesophageal reflux disease on the basis of Rome 3 criteria
Exclusion Criteria
1.history of Hypersensivity to baclofen
2.renal or hepatic failure
3.Neurological diseases
4.pregnant women
5.breastfeeding women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method alleviation of gastroesophagear reflux disesase symptoms by Mayo Gastro-esophageal Reflux questionnaire[1 month]
- Secondary Outcome Measures
Name Time Method alleviation of quality of life by SF-36 Quality of Life Questionnaire[1 month]